ArticleThrombosis journal2020

Thrombotic events following tocilizumab therapy in critically ill COVID-19 patients: a Façade for prognostic markers.

Bassam Atallah et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.